These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32764979)

  • 1. MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells.
    Zhu B; Chen W; Fu Y; Cui X; Jin L; Chao J; Yun X; Gao P; Shan S; Li J; Yin X; Zhu C; Qin X
    Onco Targets Ther; 2020; 13():6873-6884. PubMed ID: 32764979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
    Hu D; Li M; Su J; Miao K; Qiu X
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):156-165. PubMed ID: 30807260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1.
    Pan X; Hong X; Lai J; Cheng L; Cheng Y; Yao M; Wang R; Hu N
    Front Oncol; 2020; 10():441. PubMed ID: 32426266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.
    Chen L; Li Z; Hu S; Deng Q; Hao P; Guo S
    Cancer Chemother Pharmacol; 2022 Feb; 89(2):217-229. PubMed ID: 35039898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-Derived MicroRNA-221-3p Desensitizes Breast Cancer Cells to Adriamycin by Regulating
    Hong X; Pan X
    Cancer Biother Radiopharm; 2024 Aug; 39(6):463-475. PubMed ID: 38529940
    [No Abstract]   [Full Text] [Related]  

  • 6. METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner.
    Pan X; Hong X; Li S; Meng P; Xiao F
    Exp Mol Med; 2021 Jan; 53(1):91-102. PubMed ID: 33420414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
    Chen H; Pan H; Qian Y; Zhou W; Liu X
    Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0000527 Downregulation Suppresses the Development of Retinoblastoma by Modulating the miR-27a-3p/HDAC9 Pathway.
    Zuo X; Fu C; Xie J; Wang X; Yan Z
    Curr Eye Res; 2022 Jan; 47(1):115-126. PubMed ID: 34823425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2.
    Zhou L; Liang X; Zhang L; Yang L; Nagao N; Wu H; Liu C; Lin S; Cai G; Liu J
    Oncotarget; 2016 Aug; 7(32):51943-51954. PubMed ID: 27409164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
    Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
    Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC01089 inhibits the progression of cervical cancer via inhibiting miR-27a-3p and increasing BTG2.
    Li S; Han Y; Liang X; Zhao M
    J Gene Med; 2021 Jan; 23(1):e3280. PubMed ID: 33025678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M6A Promotes Colorectal Cancer Progression via Regulating the miR-27a-3p/BTG2 Pathway.
    Liu W; Zhang Z; Luo X; Qian K; Huang B; Deng J; Yang C
    J Oncol; 2023; 2023():7097909. PubMed ID: 36816363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages.
    Yao X; Tu Y; Xu Y; Guo Y; Yao F; Zhang X
    J Cell Mol Med; 2020 Sep; 24(17):9560-9573. PubMed ID: 32672418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p.
    Sun H; Sun Y; Chen Q; Xu Z
    Life Sci; 2020 Jan; 241():117161. PubMed ID: 31837329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
    Miao Y; Zheng W; Li N; Su Z; Zhao L; Zhou H; Jia L
    Sci Rep; 2017 Feb; 7():41942. PubMed ID: 28165066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microribonucleic Acid-15a-5p Alters Adriamycin Resistance in Breast Cancer Cells by Targeting Cell Division Cycle-Associated Protein 4.
    Zhang JT; Chen J; Ruan HC; Li FX; Pang S; Xu YJ; Huang DL; Wu XH
    Cancer Manag Res; 2021; 13():8425-8434. PubMed ID: 34785950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.